CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3 enrolled
Drug / intervention
Using ABTHERA Advance without a Wittmann Patchdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04986943
NCT04986943N/ACompleted
CompareCT.gov

Use of the ABTHERA ADVANCE™ Open Abdomen Dressing in Patients With Necrotizing Pancreatitis

Wake Forest University Health Sciences·observational·Posted Aug 3, 2021·Updated Aug 31, 2023

In Brief

An observational study evaluating Using ABTHERA Advance without a Wittmann Patch for Necrotizing Pancreatitis. Completed, enrolled 3 participants across 1 site.

Detailed Summary

The objective of this study is to evaluate the use of the ABTHERA ADVANCE for patients requiring open abdomen due to necrotizing pancreatitis. The institutions traditional approach is to use the ABTHERA Open Abdomen dressing with Wittmann patch. However, the ABTHERA ADVANCE has shown in vitro to have improved tension on the abdominal wall that may obviate the need for costly Wittmann patch placement.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNecrotizing Pancreatitis
CountriesUnited States
Collaborators3M

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 3, 2021
Enrollment StartOct 12, 2020
Primary CompletionMar 28, 2022
Study CompletionMar 14, 2023
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 4.9 years ago

Interventions

Using ABTHERA Advance without a Wittmann Patchdevice

In this group, patients will be receiving only the ABTHERA Advance product, without the use of the Wittmann Patch